DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Johannesson P. * et al. AstraZeneca Gothenburg, Mölndal, Sweden
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986).
J. Med. Chem. 2016;
59: 9457-9472
DOI: 10.1021/acs.jmedchem.6b01127.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.